Discovery of an Orally Bioavailable and Central Nervous System (CNS) Penetrant mGlu(7) Negative Allosteric Modulator (NAM) in Vivo Tool Compound: N-(2-(1H-1,2,4-triazol-1-yl)-5-(trifluoromethoxy)phenyl)-4-(cyclopropylmethoxy)-3-methoxybenzamide (VU6012962)

類似資料

• VU6010608, a Novel mGlu(7) NAM from a Series of N-(2-(1H-1,2,4-Triazol-1-yl)-5-(trifluoromethoxy)phenyl)benzamides
  著者:: Reed, Carson W., 等
  出版事項: (2017)
• Lead optimization of the VU0486321 series of mGlu(1) PAMs. Part 1. SAR of modifications to the central aryl core
  著者:: Garcia-Barrantes, Pedro M., 等
  出版事項: (2015)
• Discovery of VU6027459: A First-in-Class Selective and CNS Penetrant mGlu(7) Positive Allosteric Modulator Tool Compound
  著者:: Reed, Carson W., 等
  出版事項: (2020)
• Synthesis and SAR of a series of mGlu(7) NAMs based on an ethyl-8-methoxy-4-(4-phenylpiperazin-1-yl)quinoline carboxylate core
  著者:: Kalbfleisch, Jacob J., 等
  出版事項: (2020)
• Lead optimization of the VU0486321 series of mGlu(1) PAMs. Part 3. Engineering plasma stability by discovery and optimization of isoindolinone analogs
  著者:: Garcia-Barrantes, Pedro M., 等
  出版事項: (2016)